03 July 2021: Clinical Research
Factors Associated with the Prognosis of Patients with Acute Myocardial Infarction and Cardiogenic Shock
Ke-Fu Feng 1ABCDEF , Min Wu 2BC , Li-Kun Ma 1ADE*DOI: 10.12659/MSM.929996
Med Sci Monit 2021; 27:e929996
Table 1 Baseline clinical characteristics of patients in the 2 groups.
| Characteristic | Survival group (n=92) | Non-survival group (n=49) | P |
|---|---|---|---|
| Age (years) | 67.0±12.2 | 71.1±11.2 | 0.016 |
| Gender (Male; n; %) | 76 (82.6%) | 33 (67.3%) | 0.039 |
| Smoker (n; %) | 29 (31.5%) | 12 (24.5%) | 0.381 |
| Hypertension (n; %) | 47 (51.1%) | 29 (59.2%) | 0.358 |
| Diabetes mellitus (n; %) | 35 (38.4%) | 22 (44.9%) | 0.430 |
| Serum creatine ≥133 μmol/L (n; %) | 22 (23.9%) | 18 (36.7%) | 0.108 |
| Thrombolysis history (n; %) | 4 (4.3%) | 2 (4.1%) | 1.000 |
| Time from onset to surgery (h) | 8.0 (4.0–15.0) | 8.0 (6.0–13.0) | 0.845 |
| Body mass index | 23.5±2.9 | 23.4±2.6 | 0.782 |
| History of myocardial infarction (n; %) | 2 (2.2%) | 2 (4.1%) | 0.561 |
| History of PCI (n; %) | 2 (2.2%) | 0 (0.0%) | 0.299 |
| History of stroke (n; %) | 10 (10.9%) | 8 (16.3%) | 0.355 |
| HDL-C (mmol/L) | 1.04±0.41 | 0.97±0.38 | 0.345 |
| LDL-C (mmol/L) | 2.93±1.41 | 3.13±1.40 | 0.409 |
| Heart rate (beats/min) | 95.3±21.5 | 102.1±25.1 | 0.090 |
| Systolic blood pressure (mmHg) | 89.8±9.2 | 87.1±10.1 | 0.104 |
| Diastolic blood pressure (mmHg) | 56.9±8.6 | 54.5±8.8 | 0.107 |
| Cardiac troponin-I (ng/L) | 16.6±20.5 | 21.5±21.7 | 0.200 |
| Blood glucose (mmol/L) | 9.1±4.7 | 10.2±4.9 | 0.148 |
| HbA1c (%) | 6.2±1.7 | 6.5±1.8 | 0.360 |
| HbA1c – glycated hemoglobin; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; PCI – percutaneous coronary intervention. | |||